Isomorphic Labs Secures $600M to Revolutionize Drug Discovery with AI

In today's episode, we delve into Isomorphic Labs' groundbreaking $600 million funding round, led by Thrive Capital, to advance its AI-driven drug discovery platform. Discover how this Google DeepMind spin-off plans to transform the pharmaceutical industry with cutting-edge technologies like AlphaFold 3 and strategic partnerships with giants like Eli Lilly and Novartis. Join us as we explore the potential impact of AI on global health outcomes.

Sources:
https://www.prnewswire.com/news-releases/isomorphic-labs-announces-600-million-funding-to-further-develop-its-next-generation-ai-drug-design-engine-and-advance-therapeutic-programs-into-the-clinic-302415532.html
https://www.prnewswire.com/news-releases/isomorphic-labs-announces-600-million-funding-to-further-develop-its-next-generation-ai-drug-design-engine-and-advance-therapeutic-programs-into-the-clinic-302415534.html
https://www.fiercebiotech.com/biotech/ai-biotech-isomorphic-labs-hauls-600m-power-next-gen-drug-design-model
https://www.genengnews.com/topics/artificial-intelligence/deepmind-spinout-isomorphic-labs-raises-600m-toward-ai-drug-design/
https://tech.eu/2025/03/31/isomorphic-labs-nets-600m-in-first-external-funding-round/
https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-600m-external-investment-round
https://endpts.com/isomorphic-labs-gets-600m-from-thrive-gv-and-alphabet/